SCHEMBL25528546

SCHEMBL25528546

CCCc1cccc(-c2cc(Cc3c(Cl)cc(OCC(C)=O)cc3Cl)ccc2O)c1

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
THRA P10827 8/20 0.48
THRB P10828 8/20 0.48
ALOX5 P09917 2/20 0.43
CNR1 P21554 1/20 0.41
CNR2 P34972 1/20 0.41
GABRA1 P14867 1/20 0.41
GABRB2 P47870 1/20 0.41
FFAR1 O14842 2/20 0.37
PLA2G10 O15496 1/20 0.37
PLA2G2A P14555 1/20 0.37
PSMB5 P28074 3/20 0.36
HSP90AA1 P07900 1/20 0.36
HSP90AB1 P08238 1/20 0.36
MEN1 O00255 1/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
MAPT P10636 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23003609 0.92 THRA (0.59) THRATHRBALOX5CNR1CNR2
SCHEMBL25528524 0.92 THRA (0.51) THRATHRBFFAR1PLA2G10PLA2G2A
SCHEMBL25528534 0.90 THRA (0.50) THRATHRBFFAR1PLA2G10PLA2G2A
SCHEMBL25528542 0.88 THRA (0.48) THRATHRBFFAR1PLA2G10PLA2G2A
SCHEMBL23003761 0.88 THRA (0.45) THRATHRBALOX5CNR1CNR2
SCHEMBL25528562 0.88 THRA (0.52) THRATHRBALOX5PLA2G10PLA2G2A
SCHEMBL25528603 0.87 THRB (0.49) THRATHRBFFAR1PLA2G10PLA2G2A
SCHEMBL25528523 0.87 THRA (0.51) THRATHRBFFAR1PLA2G10PLA2G2A
SCHEMBL25528706 0.86 THRA (0.57) THRATHRBFFAR1PLA2G10PLA2G2A
SCHEMBL23003817 0.86 THRA (0.43) THRATHRBALOX5MEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11667606-B2 Thyromimetics AUTOBAHN THERAPEUTICS, INC. (US) 2023-06-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11667606-B2 Thyromimetics TPO, TSHR, TTR THRA 4/4885THRB 9/4885ALOX5 1530/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.